Zydus Hospira Oncology Private Limited Oxaliplatin Export Data — India (DGFT 2022–2026)

Name: Zydus Hospira Oncology Private Limited Oxaliplatin Export Records India — #9 Exporter, 17 Shipments, $850.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Oxaliplatin

India Pharmaceutical Trade Intelligence

$46.6M249 Suppliers123 CountriesHS 30049049

ExportsIndia → GERMANY21.5%India → RUSSIA13.9%

ImportsARGENTINA → India$44.5K ITALY → India$20.0K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Zydus Hospira Oncology Private Limited — Oxaliplatin Exporter #9 | $850.0K Trade Value | TransData Nexus | TransData Nexus

Zydus Hospira Oncology Private Limited — Oxaliplatin Exporter Profile

Indian Pharmaceutical Exporter · #9 for Oxaliplatin · $850.0K export value · DGFT Verified

Zydus Hospira Oncology Private Limited is the #9 Indian exporter of Oxaliplatin with $850.0K in export value and 17 verified shipments. Zydus Hospira Oncology Private Limited holds a 1.8% market share in Oxaliplatin exports across 10 countries. The company exports 5 pharmaceutical products worth $4.7M across 2 therapeutic categories.

Zydus Hospira Oncology Private Limited — Oxaliplatin Export Profile: Buyers & Destinations

Zydus Hospira Oncology Private Limited Oxaliplatin export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Hospira Oncology Private Limited Export Oxaliplatin?

Country	Value	Shipments	Share
THAILAND	$196.7K	4	32.8%
JAPAN	$150.0K	3	25.0%
UNITED STATES OF AMERICA	$100.0K	2	16.7%
BELGIUM	$50.0K	1	8.3%
AUSTRALIA

Who Are the Top Buyers of Oxaliplatin from Zydus Hospira Oncology Private Limited?

Buyer	Country	Value	Orders
XXIZEXXSERXXCE XXMPAXX BV	BELGIUM	$430.8K	10
PFIZER SERVICE COMPANY BV	AUSTRALIA	$168.7K	5
COSTAPHARM SOCIEDAD ANONIMA	COSTA RICA	$412	1
XXIZEXXLIMITEDXXDISXXVERXXPARXX	UNITED KINGDOM	$19	1

Zydus Hospira Oncology Private Limited supplies Oxaliplatin to 4 buyers globally. The largest buyer is XXIZEXXSERXXCE XXMPAXX BV (BELGIUM), followed by PFIZER SERVICE COMPANY BV (AUSTRALIA) and COSTAPHARM SOCIEDAD ANONIMA (COSTA RICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Oxaliplatin Formulations Does Zydus Hospira Oncology Private Limited Export?

Product Description / Formulation	Value	Shipments
OXALIPLATIN INJ. 100MG US -F000207029	$100.0K	2
OXALIPLATIN INJ. 50MG TH -F000041001	$100.0K	2
OXALIPLATIN INJ. 100MG TH -F000041172	$96.7K	2
OXALIPLATIN INJ.100MG-EG-F000057495	$50.0K	1
OXALIPLATIN INJ. 50MG JP (H000015216	$50.0K	1
OXALIPLATIN INJ. 200MG JP H000015218	$50.0K	1
OXALIPLATIN INJ. 200MG JP (H000015218)	$50.0K	1
OXALIPLATIN INJ.100MG AU - F000046484	$34.9K	1
OXALIPLATIN INJ. 100MG PH F000036304	$24.8K	1
OXALIPLATIN INJ. 50MG -SG-F000054120	$19.1K	1

Zydus Hospira Oncology Private Limited exports 14 distinct Oxaliplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OXALIPLATIN INJ. 100MG US -F000207029 with 2 shipments worth $100.0K.

How Does Zydus Hospira Oncology Private Limited Compare to Nearest Oxaliplatin Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	VENUS REMEDIES LIMITED	$1.5M	132	14	$11.3K
5	GLAND PHARMA LIMITED	$1.0M	20	1	$50.0K
9	ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED ★	$850.0K	17	10	$50.0K
10	INTAS PHARMACEUTICALS LIMITED	$790.8K	32	6	$24.7K
11	NV REMEDIES PRIVATE LIMITED	$651.6K	16	4	$40.7K

Zydus Hospira Oncology Private Limited ranks #9 among 249 Indian Oxaliplatin exporters. Average shipment value of $50.0K compared to the market average of $130.9K. The closest competitors by value are VENUS REMEDIES LIMITED and GLAND PHARMA LIMITED.

Which Indian Ports Ship Oxaliplatin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	535	17.4%
SAHAR AIR CARGO ACC (INBOM4)	453	14.7%
DELHI AIR	436	14.2%
SAHAR AIR	410	13.3%
CHAWAPAYAL ICD (INCPR6)	110	3.6%
Bombay Air	108	3.5%
NHAVA SHEVA SEA (INNSA1)	97	3.1%
CHAWAPAYAL ICD	95	3.1%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Hospira Oncology Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 17 individual customs records matching Zydus Hospira Oncology Private Limited exporting Oxaliplatin, covering 14 formulations to 10 countries via 4 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 123+ countries, 693+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Oxaliplatin

Oxaliplatin

Zydus Hospira Oncology Private Limited — Oxaliplatin Exporter Profile

Zydus Hospira Oncology Private Limited — Oxaliplatin Export Profile: Buyers & Destinations

Where Does Zydus Hospira Oncology Private Limited Export Oxaliplatin?

Who Are the Top Buyers of Oxaliplatin from Zydus Hospira Oncology Private Limited?

What Is India's Total Oxaliplatin Export Value and How Much Does Zydus Hospira Oncology Private Limited Contribute?

What Is the Average Shipment Value for Zydus Hospira Oncology Private Limited's Oxaliplatin Exports?

How Does Zydus Hospira Oncology Private Limited Compare to Other Indian Oxaliplatin Exporters?

What Oxaliplatin Formulations Does Zydus Hospira Oncology Private Limited Export?

Regulatory Requirements: Exporting Oxaliplatin to Key Markets

Japan — PMDA

How Does Zydus Hospira Oncology Private Limited Compare to Nearest Oxaliplatin Exporters?

Which Indian Ports Ship Oxaliplatin Exports?

What Other Advanced Oncology Products Does Zydus Hospira Oncology Private Limited Export?

About Zydus Hospira Oncology Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Oxaliplatin Export Data from Zydus Hospira Oncology Private Limited

Oxaliplatin Stats

Company Overview

Top Products by Zydus Hospira Oncology Private Limited

Related Analysis

Need Detailed Export Data?

Data Source